Skip to main content
. 2022 Nov 18;51(D1):D1353–D1359. doi: 10.1093/nar/gkac1046

Figure 2.

Figure 2.

New data in the Open Targets Platform. Additional sources of target–disease evidence and new types of annotation for targets diseases and drugs during the last 2 years.